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Abstract
Objective—Mental health intervention research requires clear and accurate specification of
treatment conditions in intervention studies. Measures are increasingly available for community-
based interventions for persons with serious mental illnesses. Measures must go beyond structural
features to assess critical processes in interventions. They must also balance effectiveness,
adequate coverage of active treatment elements, with efficiency, the degree to which measures
may be used cost-effectively. The context of their use is changing with the emergence of new
frameworks for implementation research and quality improvement.
Methods—The focus, content, and results of preliminary studies of four recently developed
fidelity measures are described. Measures respectively assess fidelity to case management,
cognitive therapy for psychosis, illness management and recovery, and assertive community
treatment.
Results—Fidelity measures described assess interventions in a range of treatment contexts from
dyads to teams. Each measure focuses assessment resources on the elements critical to the
respective intervention. Each has demonstrated coverage of its target intervention and satisfactory
psychometric properties and is related to outcomes. Measures have been used for training, quality
improvement, or certification. Current fidelity measures assess domains and have uses beyond
their nominal position in implementation and quality frameworks.
Conclusion—Process components in community-based interventions can be effectively assessed
in fidelity measures. Omission of elements assessing potentially critical, active treatment
components poses risk to both research and practice until there is evidence to demonstrate they are
non-essential. Further development of fidelity measurement theory and approaches should
articulate with development of theory and methods in implementation science.
Mental health intervention research requires clear and accurate specification of independent
variables actually operating in studies. Inferences about effects in experimental studies, for
example, depend upon fidelity: therapists’ adherence to the intended treatment, their
competence to apply it, and sufficient differentiation across conditions (1, 2). Although
empirical verification of fidelity has been reported infrequently in psychological treatment
research (3), fidelity has recently received greater attention in research on community-based
psychosocial interventions for persons with serious mental illnesses. These program-based
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interventions are inherently more complex and less amenable to full specification in manuals
than interventions delivered by a single clinician, often including such elements as aspects
of organization, caseload, types of treatments and other services provided, as well as
interactions with other programs (4). Fidelity measurement strategies and measures have
been developed and used with a wide range of such programs for research and practice (5–
11).
The principal research uses of program fidelity measures are to monitor and ensure
adherence to particular interventions and to identify their critical ingredients. They also
serve as operational syntheses of prior research and as vehicles to disseminate information to
the field about essential features of evidence-based practices (4). The demands of multiple
uses pose significant challenges for fidelity measure design. One is selection of features to
include. Critical ingredients are identified through theory and empirical research on the
active mechanisms that are expected to yield intended outcomes; with potentially multiple
organizational levels, contributing mechanisms, and potential assessment points, program-
based models present developers with a multitude of options. A second challenge is the need
to balance effectiveness, the degree to which fidelity measures and methods capture the
essential features of an intervention reliably and validly, with efficiency, the degree to which
the tools can be applied cost-effectively such that the real gains from use in ordinary settings
warrant the effort required to use them (12). Corresponding to the complexity of treatments,
contexts, and possible uses, developers of fidelity measures have made a wide range of
choices in balancing effectiveness and efficiency.
Consideration of a number of conceptual frameworks within which fidelity measures operate
suggests why there is such variation. Within the classic structure-process-outcome quality
framework (13), fidelity measures typically include both structure and process elements.
Although fidelity measures have sometimes emphasized more accessible structural features
–e.g., group size, duration of treatment – less tangible processes may be essential to program
integrity (7), and there are risks to both research and practice posed by over-emphasizing
structure (14–16). Such misplaced emphasis can follow from weak theory, since fidelity
measures have been described as representing program theory, or theory of action of the
intervention (14, 17). What is included in a fidelity measure will thus depend upon what
actions and at what level the intervention is defined. In some cases, this represents a
departure from program theory as such, which specifies mechanisms of change, to include
implementation theory, which specifies how a program is carried out (18). A more recent
model of implementation research, with primary domains of intervention strategies,
implementation strategies, and three types of outcome domains – implementation, service,
and client – would place fidelity as one of a number of implementation outcomes (19).
However, some fidelity measures, including two described here, have addressed
implementation features in three or four of these five domains. This implementation research
framework itself draws on a model for assessing change at four levels – individual, group/
team, organization, and larger system/environment (20); again, fidelity measures can span
multiple levels. Finally, a recent heuristic model for ensuring quality of implementation of
evidence-based practices proposes four main strategic categories: policy and administration;
training and consultation; team operations; and program evaluation (21). Fidelity assessment
is placed in the last category, but it can also support other strategies.
We describe four recent fidelity measures for community-based interventions for people
with serious mental illness to illustrate a range of approaches within this context. Overall
they reflect advances in effective measurement of critical processes, but they differ in terms
of where and how they focus within those frameworks for theory, quality, and
implementation. These measures are summarized in Table 1 and listed along a continuum of
complexity of program levels.
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Recent measures of service fidelity
Cognitive Therapy for Psychosis Adherence Scale
Between 25 and 40 percent of people with a schizophrenia-spectrum disorder experience
persistent psychotic symptoms (22, 23), which are associated with high levels of distress,
functional impairment, and increased vulnerability to relapses (24, 25). To address this
problem, cognitive-behavioral therapy (CBT) for psychosis was adapted based on the
principles of CBT that were initially developed for the treatment of depression and anxiety
(26, 27) and that emphasize treatment components such as the “normalization” of psychotic
symptoms, teaching effective coping strategies for persistent symptoms, and critically
examining and challenging thoughts and beliefs underlying psychotic symptoms (28–30).
Over the past two decades, over 30 randomized controlled trials have been conducted to
evaluate the effects of CBT for psychosis, with the results indicating significant effects on
the reduction of psychotic, negative, mood, and social anxiety symptoms (31). CBT for
psychosis is a recommended treatment for schizophrenia both in the most recent NICE
guidelines from Great Britain (32) and the PORT recommendations in the U.S. (33).
In order to evaluate therapist adherence to the elements of CBT for psychosis defined by
Fowler and colleagues (29), Startup and colleagues (34) developed the Cognitive Therapy
for Psychosis Adherence Scale (CTPAS), which included 12 items, each rated on 7-point
Likert scales, with assessments based on audiotapes of treatment sessions. Ratings on the
scale pertain to specific therapist behaviors, such as “Assessing psychotic experiences” and
“Validity testing.” Startup and colleagues (34) demonstrated that reliable ratings could be
obtained with the CTPAS. A principal components factor analysis indicated two factors,
corresponding to focus on problems and focus on delusions. This scale was used to
document therapist fidelity to CBT for psychosis in two clinical trials (35, 36).
The CTPAS was subsequently revised (R-CTPAS) by adding nine additional items, and
changing the rating scale in order to provide separate ratings of therapist adherence to the
CBT for psychosis model, and the frequency of specific therapist activities (37). Adherence
is conceptualized as therapist activities described in the manual (29) that are delivered
competently, as defined by practices that are individualized to the client’s presenting
problems, matched to the person’s understanding, and carried out collaboratively. Frequency
items are recorded for specific therapist activities, regardless of whether they are adherent or
not. High inter-rater reliability ratings were obtained. A principal components factor analysis
of the presence of specific therapist activities demonstrating adherence to the model yielded
three factors corresponding to “engagement and assessment,” relapse prevention,” and
“formulation and schema work.” Concurrent validity was shown by demonstrating moderate
associations between ratings on the CTPAS and the Cognitive Therapy Scale (38), which
was developed to evaluate fidelity to CBT for depression. The CTPAS has been used to
ensure adherence of therapists delivering CBT for psychosis in randomized controlled trials
(39), and to compare the skills of clinicians working on a research project with those
providing routine clinical practice (37).
Strengths Model case management Fidelity Scale
The purpose of the Strengths Model of case management, first formulated in the early
1980’s, is to help people with psychiatric disabilities to attain the goals that they set
themselves by identifying, securing and sustaining the range of resources, both
environmental and personal, needed to live, play and work in a normally interdependent way
in the community (40). The focus is on individual and community strengths and assets in the
service of goal achievement. The Strengths Model has been the subject of four experimental/
quasi-experimental studies (41–44) and five non-experimental studies (45–49). Results have
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been consistently positive with reduction in symptoms and improved social functioning
being the most frequent finding. This body of research has been criticized for small sample
sizes and the varied measures employed (50). Of particular concern is the lack of systematic
monitoring of intervention implementation.
The impetus to develop a Strengths Model Fidelity Scale (SM-FS) was threefold. First,
future research on the Strengths Model needed a reliable method for monitoring the
intervention implementation. Second, the mental health authority in Kansas created an
enhanced Medicaid reimbursement rate for providers who delivered high fidelity Strengths
Model case management and other states were pursing similar arrangements. They needed a
reliable method for ascertaining fidelity. Third, since the idea of strengths-based practice has
gained such currency, there was a need to distinguish between the rhetoric of programs and
actual practice.
The SM-FS contains three major domains: structure (e.g. caseload size, use of group
supervision), supervision (e.g. field mentoring, review and feedback on the use of clinical
tools), and clinical practice (e.g. use of the strengths assessment and personal recovery plan,
use of naturally occurring community resources, hope-inducing behavior)(51). The measure
uses the five point anchored scale format used in many fidelity measures (11). Scores can
range from 11 to 55 with 45 defined as “good” fidelity. It uses multiple sources of data
including case records; interviews with consumers, case managers, and supervisors; and
direct observation of practice. SM-FS has face validity with expert item reviews.
One study showed the predictive validity of SM-FS for team performance in terms of
consumer outcomes (52). The core outcomes included psychiatric hospitalization,
competitive employment, involvement in higher education, and independent living. Fidelity
reviews were conducted at baseline and then every six months during the first 18 months of
implementation. Each review was conducted by at least two consultant-trainers. Inter-rater
reliability (intraclass correlation) between the two raters of the fidelity scale was .97
representing a high level of agreement. Internal consistency (Cronbach’s alpha) for the 11
items was .98. Consumer outcomes were reported by the participating team case managers
when fidelity reviews occurred. The data contained 14 case management teams representing
10 agencies serving an average of 953 consumers diagnosed with a serious mental illness
over an 18 month period of time. The study revealed that consumer outcomes improved over
time and the improvement was explained by the increase in the fidelity score indicating
predictive validity. Concurrent correlations between the fidelity score and outcomes showed
expected directions, which also support the associations between fidelity and outcomes.
Illness Management and Recovery Program Fidelity Scale
The Illness Management and Recovery (IMR) program was developed in order to teach
illness self-management skills to people with severe mental illness (53). A comprehensive
review of illness self-management strategies was first conducted, which identified
psychoeducation, behavioral tailoring for medication adherence, developing a relapse
prevention plan, coping skills training, and social skills training to improve social support as
empirically supported interventions (54). These strategies were then incorporated into a
comprehensive, integrated program including ten different “modules” or topic areas aimed
at teaching illness self-management strategies in the service of helping clients achieve
personally meaningful, “recovery” goals. The IMR program can be implemented either
individually or in groups, and generally requires 4–5 months of twice weekly meetings, or
9–10 months of weekly meetings to complete.
The IMR Fidelity Scale (IMR-FS) was developed to evaluate the adherence of clinicians to
the principles of the IMR Program. In contrast to the R-CTPAS, which focuses on
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evaluating the fidelity of individual clinicians to the CBT for psychosis treatment model, the
IMR-FS focuses on the evaluation of an overall program (i.e., all the clinicians together) to
the principles and defining elements of IMR. The IMR-FS includes 13 items, each rated on
5-point behaviorally anchored scales, which tap a combination of specific structural aspects
regarding how the program should be delivered (number of people in sessions, program
length, comprehensiveness of curriculum provision of handouts), the provision of specific
empirically supported components in IMR sessions (psychoeducation, behavioral tailoring,
relapse prevention plan, coping skills training, and social skills training), and adherence to
specific principles that guide implementation of the overall IMR program (goal setting and
follow-up; use of educational, motivational, and cognitive-behavioral teaching strategies;
involvement of significant others). Ratings are usually conducted by two assessors, based on
a combination of inspection of charts, meetings with clinicians, clients, and supervisors, and
direct (limited) observation of IMR sessions.
Good inter-rater reliability has been shown for the IMR-FS, which was also found to be
sensitive to change over two years following training and consultation in the IMR program
across 12 community mental health centers participating in the National Implementing
Evidence-Based Practices project (11). The IMR-FS has also been used to document fidelity
to the IMR model in three randomized controlled trials comparing IMR to usual services
(55–57). Interestingly, in one of these studies IMR was implemented at 12 sites, of which 9
showed high fidelity to the IMR program. When analyses were restricted to the 9 high
fidelity sites, somewhat stronger effects were found than in the intent-to-treat analyses that
included all 12 sites (56).
Validation work on the IMR-FS has yet to be conducted, although there are several possible
approaches. Research could be conducted to evaluate whether total scores on the IMR-FS at
different agencies providing the IMR program are related to improvements in domains
targeted by the program, such as illness self-management, hospitalizations, or functioning.
In addition, research could evaluate whether ratings on some of the items of the IMR-FS are
significantly related to independent fidelity measures tapping those same constructs. For
example, one would expect that higher scores on the motivational teaching strategies item of
the IMR-FS would be related to greater clinical competence on the motivational
interviewing subscale of the Yale Adherence and Competence Scale (58).
The Tool for Measurement of Assertive Community Treatment
Assertive community treatment (ACT) was developed as a comprehensive program to
provide the full array of treatments, services, and supports needed by persons with severe
mental disorders and significant psychiatric disabilities to establish and maintain fulfilling
lives in the community (59, 60). The program is the single point of responsibility for
enrolled consumers, has a small caseload of approximately 100 consumers shared across a
10–12-member multidisciplinary team, and provides highly individualized, integrated
services in vivo, whenever, wherever, and for as long as needed in consumers’ daily lives.
The model incorporates carefully specified procedures to track and respond to consumer
needs, deploying staff as needed. As definitions for optimal treatment and expectations for
treatment goals have changed over time, the practice of ACT has also evolved, incorporating
other evidence-based practices in treatment (10) within an overall recovery orientation (61).
Following development of preliminary fidelity measures (6, 62), the Dartmouth Assertive
Community Treatment Scale (7), though developed for a particular study (63), became the
standard fidelity measure for ACT and has been used widely in studies up to the present (11,
64, 65). Because it was available prior to publication of the first ACT manual (60) and had a
clear and accessible format and protocol, it was frequently used as a guide to implementing
the program despite authors’ assertions that some key processes were not assessed. While
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not critical in its original application (66), the emphasis on structural features and omission
of some critical process risked weaker implementation and research inferences elsewhere,
especially as the ACT model evolved.
The Tool for Measurement of ACT (TMACT) (16) was designed to address these issues. It
assesses use of evidence-based practices – e.g., supported employment, integrated dual
disorder treatment – within the ACT model, includes items for consumer recovery
orientation, and strengthens measurement of team functioning. It has 47 items in six
subscales respectively defining operations and structure, core team, specialist team, core
practices, evidence-based practices, and person-centered planning and practices. A protocol
specifies the fidelity assessment process and provides interview questions, rules for scoring
all items, and formats for collecting data and providing feedback. Items on each evidence-
based practice are derived from respective full fidelity scales (11). ACT staff function as
both specialists and generalists informed by others’ specialist services, so staff roles are
assessed relative to other staff as well as consumers. Recovery orientation is built into items
assessing person-centered planning and practices and is more generally reflected throughout
the measure in assessing the focus of treatment and interactions with consumers. DACTS
and TMACT scores were compared for 10 teams over 18 months; significant differences
between the two measures varied over time and were a function of lower fidelity in key
areas not measured by the DACTS, confirming the TMACT as a more comprehensive and
higher standard than the DACTS and more sensitive to change (16).
Discussion
Advances in research on community-based interventions will depend in part upon advances
in our ability to measure whether they are being delivered as intended. The fidelity measures
described above for four different intervention models for people with severe mental
disorders represent improvements in this respect. While all of these measures include
structural elements, they also include assessment of specific processes demonstrated or
hypothesized as critical to successful delivery of the intervention. They were designed for
use in a number of research purposes, such as validating inclusion of sites or practitioners in
studies, indicating strength of intervention, or identifying critical ingredients. And their
intended uses go beyond research: one or more is used to accredit programs for enhanced
reimbursement rates, to certify individual clinicians, or as a tool for training and quality
improvement.
They differ in important respects following from differences in program and implementation
theory underlying their respective interventions. At the programmatically simplest level, the
CBT for psychosis intervention is specified strictly in terms of dyadic interaction. At the
other extreme of programmatic complexity, the ACT model includes specifications for
program-level structures and processes theoretically required to ensure optimal delivery of
services at the dyadic level. Current fidelity measurement as exemplified by these recent
measures expands In practice beyond the respective niches suggested by recent frameworks
for implementation science and quality improvement (19–21).
This broad practical and conceptual scope in what we currently define as fidelity
measurement suggests an important future need. There are calls for refinement in program
and implementation theory, as well as development of measures of implementation fidelity
(17, 19). The field would gain from greater clarity in concept and definition. The term
fidelity has merit as representing a general concept, but we would benefit from articulation
of a typology of fidelity measurement linked to emerging frameworks for implementation
and quality.
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The role of fidelity measures in research could also be better clarified. For example,
McGrew faulted the TMACT authors for including items that had not been individually
demonstrated to predict outcomes in ACT (67). The authors’ response was that fidelity
measures had rarely been pre-validated at the item level and that the TMACT was just the
sort of refinement of program theory called for, based on related evidence, and necessary to
move the science of this intervention forward (17, 68). Further consideration of this issue is
warranted.
Validation is a related need. The four measures described here have made variable use of
one or more of the approaches described by Mowbray and colleagues: reliability, structural
analysis, known groups, convergent validity, and outcome prediction; but these must be used
judiciously (14). Internal consistency, for example, may apply poorly to measurement of
domains not representing a single underlying construct; outcome prediction may be
uninformative or misleading where program variation is insufficient; and overall test-retest
and inter-rater reliability may present practical challenges for program-wide assessments.
However, several of these, especially convergent validity, could more routinely apply to
measure components. And validation of choice of method would be important and feasible
in complex programs, for example, by evaluating program-level items against aggregated
results from individual-level items.
In the absence of the suggested theoretical and empirical work it would be difficult to judge
the respective choices made within the four fidelity measures in balancing effectiveness and
efficiency. Respective descriptions and Table 1 indicate an adaptation of both coverage and
methods to the domains assessed. In the normal scientific context of testing and refinement,
increasing effectiveness should also yield improved efficiency over time. All four entail
considerable effort, albeit of varying types, suggesting the importance of additional work to
quantify value added and establish cost-effectiveness. How much effort in fidelity
assessment is warranted, and to what degree of precision, is unclear. However, there is
substantial evidence that higher fidelity is generally correlated with outcome; establishment
of high fidelity early on should yield substantial benefit. Even a full TMACT assessment
with consultative feedback requires less than 0.5% of the annual effort of a team, a modest
marginal cost for expected treatment improvement from assessment of either a new team or
one showing intermediate performance, and there is reasonable concern and some evidence
that diluted fidelity measurement in an environment of complex incentives may weaken both
practice and research findings (16, 68). Further work is needed on development of low-risk
strategies for titration of ongoing fidelity assessment effort (64).
Conclusions
Fidelity measurement in mental health services research is at a promising if uncertain point.
New measures are being developed to measure and guide fidelity of emerging and enhanced
practices in serving persons with serious mental illnesses in the community. Four recent
measures illustrate this progress. At the same time, the context of use is rapidly changing as
an emerging implementation science begins to articulate frameworks for addressing the
compelling translational challenge of developing the necessary knowledge to establish and
maintain evidence-based practices in usual care settings. Further refinement and clarification
of the science and practice of fidelity measurement, along with an expanded view of its
useful place in these frameworks, should be a part of that development.
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